Leprosy other diagnostic studies: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 12: | Line 12: | ||
===Skin Biopsy=== | ===Skin Biopsy=== | ||
A biopsy of the skin lesion should be performed and stained according to the ''Fite-Faraco'' technique (a especially designed protocol for staining the leprosy ''bacilli''). | A [[biopsy]] of the [[skin lesion]] should be performed and [[stained]] according to the ''Fite-Faraco'' technique (a especially designed protocol for [[staining]] the leprosy ''[[bacilli]]''). | ||
According to the pole of leprosy in that | According to the pole of leprosy in that patient, typical findings include: | ||
* Tuberculoid pole | * '''Tuberculoid pole''': | ||
:* ''Bacilli'' are commonly not observed. | :* ''[[Bacilli]]'' are commonly not observed. | ||
:* Granulomas commonly found. | :* [[Granulomas]] commonly found, containing: | ||
:* Common nerve involvement. | ::* [[Epithelioid cells]]. | ||
* Lepromatous pole | ::* [[Lymphocytic infiltrate]]. | ||
::* [[Langerhans cells]]. | |||
:* Common [[nerve]] involvement. | |||
* Lepromatous pole: | |||
:* [[Inflammatory infiltrate]]. | |||
:* [[Virchow cells]] loaded with ''[[bacilli]]''. | |||
:* Loss of [[adnexal structures]]. | |||
===Lepromin Test=== | ===Lepromin Test=== | ||
Revision as of 15:57, 6 July 2014
|
Leprosy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Leprosy other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Leprosy other diagnostic studies |
|
Risk calculators and risk factors for Leprosy other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Although there are no laboratory studies to help in the diagnosis of leprosy, other studies such as biopsy of skin lesions and skin smear tests have an important contribution for the diagnosis of leprosy in patients in whom the diagnosis is suspected from the clinical presentation.
Other Diagnostic Studies
Smear test
May be obtained from any skin lesion, from the nasal mucosa and/or the ear lobe. This test has a sensitivity of 50% and a specificity of 100%. After collection of the [Laboratory specimen|specimen]], in order to visualize the bacteria, the Ziehl-Neelsen stain should be used.[1][2][3][4]
Skin Biopsy
A biopsy of the skin lesion should be performed and stained according to the Fite-Faraco technique (a especially designed protocol for staining the leprosy bacilli). According to the pole of leprosy in that patient, typical findings include:
- Tuberculoid pole:
- Bacilli are commonly not observed.
- Granulomas commonly found, containing:
- Common nerve involvement.
- Lepromatous pole:
- Inflammatory infiltrate.
- Virchow cells loaded with bacilli.
- Loss of adnexal structures.
Lepromin Test
Serology
Polymerase Chain Reaction
References
- ↑ Eichelmann, K.; González González, S.E.; Salas-Alanis, J.C.; Ocampo-Candiani, J. (2013). "Leprosy. An Update: Definition, Pathogenesis, Classification, Diagnosis, and Treatment". Actas Dermo-Sifiliográficas (English Edition). 104 (7): 554–563. doi:10.1016/j.adengl.2012.03.028. ISSN 1578-2190.
- ↑ Hatta M, van Beers SM, Madjid B, Djumadi A, de Wit MY, Klatser PR (1995). "Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia". Trans R Soc Trop Med Hyg. 89 (4): 381–5. PMID 7570870.
- ↑ Aggarwal A, Pandey A (2010). "Inverse sampling to study disease burden of leprosy". Indian J Med Res. 132: 438–41. PMID 20966523.
- ↑ Ramaprasad P, Fernando A, Madhale S, Rao JR, Edward VK, Samson PD; et al. (1997). "Transmission and protection in leprosy: indications of the role of mucosal immunity". Lepr Rev. 68 (4): 301–15. PMID 9503866.